Ebastine targets HER2/HER3 signaling and cancer stem cell traits to overcome trastuzumab resistance in HER2âpositive breast cancer.
依巴斯汀靶向 HER2/HER3 信号传导和癌症干细胞特性,以克服 HER2 阳性乳腺癌的曲妥珠单抗耐药性。
期刊:International Journal of Molecular Medicine
影响因子:5.8
doi:10.3892/ijmm.2026.5751
Jung Eunsun, Kim Ji Young, Ko Dongmi, Seo Juyeon, Lee Sang Yoon, Lee Daeun, Kim Subeen, Park Minsu, Kim Seongjae, Park Soeun, Lee Kyoungmin, Kang Yong Koo, Nam Kee Dal, Kim Yoon-Jae, Seo Jae Hong